New Study for People Carrying the APOL1 AMKD Gene
At ANC, we’re always looking for ways to improve care and bring cutting-edge research to our patients. We recently sat down with Dr. Doyle to talk about an exciting opportunity: the Horizon clinical trial by Maze Therapeutics, a national study focused on addressing genetic kidney disease in Black Americans. What Is the Horizon Trial […]
Exciting Opportunities in Kidney Research at ANC
ANC’s Clinical Trial Research Here at ANC, we are thrilled to announce our participation in global clinical trials focused on developing new treatments for people with kidney disease. We are partnering with Davita Clinical Research to bring opportunities for our patients to have access to developing, cutting- edge treatments early on and we are excited […]